Chimeric hepatitis E virus-like particle as a carrier for oral-delivery-Reference-Cited by-同舟云学术

Chimeric hepatitis E virus-like particle as a carrier for oral-delivery

Published:2013-01 Issue:2 Volume:31 Page:417-424
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Jariyapong Pitchanee,Xing Li,van Houten Nienke E.,Li Tian-Cheng,Weerachatyanukul Wattana,Hsieh Benjamin,Moscoso Carlos G.,Chen Chun-Chieh,Niikura Masahiro,Cheng R. Holland

Funder

NIH NCI pilot

NIH grant

UC Discovery Programs

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference35 articles.

1. Mucosal immunity and vaccines;Holmgren;Nat Med,2005

2. Vaccination strategies for mucosal immune responses;Ogra;Clin Microbiol Rev,2001

3. Virus-like particles-universal molecular toolboxes;Ludwig;Curr Opin Biotechnol,2007

4. Biological containers: protein cages as multifunctional nanoplatforms;Uchida;Adv Mater,2007

5. Immunity against both polyomavirus VP1 and a transgene product induced following intranasal delivery of VP1 pseudocapsid-DNA complexes;Clark;J Gen Virol,2001

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plant-Produced Chimeric Hepatitis E Virus-like Particles as Carriers for Antigen Presentation;Viruses;2024-07-08

2. Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection;Hepatology Research;2024-06-14

3. Viral protein-based nanoparticles (part 2): Pharmaceutical applications;European Journal of Pharmaceutical Sciences;2023-10

4. Viral protein nanoparticles (Part 1): Pharmaceutical characteristics;European Journal of Pharmaceutical Sciences;2023-08

5. Biological evaluation of integrin α3β1-targeted 68Ga-labeled HEVNPs in HCT 116 colorectal tumor-bearing mice;European Journal of Pharmaceutical Sciences;2023-01